Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
87
PHILIPPINES:33
SFDA:31
NMPA:23
Drug Approvals
Pasireotide Diaspartate Injection
- Product Name
- 丝尼芬
- Approval Number
- H20150317
- Approval Date
- Jul 3, 2019
NMPA
Pasireotide Diaspartate Injection
- Product Name
- 丝尼芬
- Approval Number
- H20150318
- Approval Date
- Jul 3, 2019
NMPA
Pasireotide Diaspartate Injection
- Product Name
- 丝尼芬
- Approval Number
- H20150316
- Approval Date
- Jul 3, 2019
NMPA
Pasireotide Diaspartate Injection
- Product Name
- 丝尼芬
- Approval Number
- H20150315
- Approval Date
- Jul 3, 2019
NMPA
Pasireotide Diaspartate Injection
- Product Name
- 丝尼芬
- Approval Number
- H20150320
- Approval Date
- Jul 3, 2019
NMPA
Pasireotide Diaspartate Injection
- Product Name
- 丝尼芬
- Approval Number
- H20150319
- Approval Date
- Jul 3, 2019
NMPA
Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation, Hard Capsules
- Product Name
- 杰润
- Approval Number
- H20170391
- Approval Date
- Apr 11, 2019
NMPA
Indacaterol Maleate and Glycopyrronium Bromide Powder for Inhalation, Hard Capsules
- Product Name
- 杰润
- Approval Number
- H20170390
- Approval Date
- Apr 11, 2019
NMPA
Glycopyrronium Bromide Powder for Inhalation, Hard Capsules
- Product Name
- 希润
- Approval Number
- H20180002
- Approval Date
- Jan 30, 2019
NMPA
Glycopyrronium Bromide Powder for Inhalation, Hard Capsules
- Product Name
- 希润
- Approval Number
- H20180003
- Approval Date
- Jan 30, 2019
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found